Top Markets
Coin of the day
Perseus Proteomics Inc. Perseus Proteomics Inc.

Perseus Proteomics Inc.

4882
Classifica tra le azioni #30348
Based in Tokyo, Japan, Perseus Proteomics Inc. operates as a biotechnology... Based in Tokyo, Japan, Perseus Proteomics Inc. operates as a biotechnology venture specializing in the development of antibody-based therapeutics for various ailments, including cancer. Its core operations encompass pioneering antibody discovery, alongside providing extensive research support services. These services include hybridoma antibody sequencing, the production of antibody proteins, and undertaking contract antibody research projects. Furthermore, Perseus Proteomics supplies its own antibody products to the market. The company boasts a robust development pipeline featuring several promising candidates: PPMX-T001, an antibody targeting hepatocarcinoma; PPMX-T002, an oncology therapeutic; PPMX-T003, designed for the treatment of adult T-cell leukemia/lymphoma; and PPMX-T004, an innovative antibody-drug conjugate. Established in 2001, the firm maintains its headquarters in the Japanese capital.
Prezzo delle azioni
$0.93298493
Capitalizzazione di mercato
$17.19M
Variazione (1 giorno)
-1.38%
Variazione (1 anno)
-62.47%
Paese
JP
Scambia Perseus Proteomics Inc. (4882)

Categoria

Storico del prezzo dell'azione per Perseus Proteomics Inc. (4882)
Prezzo di chiusura più alto: $0.94 il 2026-08-01

Prezzo di chiusura più basso: $7.34 il 2021-06-01
Storico del prezzo dell'azione di Perseus Proteomics Inc. dal 2021 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) -5.78%
2025 -60.94%
2024 -2.22%
2023 82.81%
2022 -26.01%
2021 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$1.23K 74.37%
US
$271.04 52.44%
US
$258.13 25.19%
US
$477.05 41.32%
CH
$135.49 59.53%
US